Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1945-1956 of 2541 results
Page 163 of 212
Key Publications February 24, 2017

The impact of inflammation on the obesity paradox in coronary heart disease.

Int J Obes (Lond). 2016;40:1730-1735

De Schutter A, Kachur S, Lavie CJ, Boddepalli RS, Patel DA, Milani RV
Cardiovascular Disease Inflammation Obesity
Key Publications February 24, 2017

Recent trends in weight loss attempts: repeated cross-sectional analyses from the health survey for England.

Int J Obes (Lond). 201;40:1754-1759

Piernas C, Aveyard P, Jebb SA
Cardiovascular Disease Obesity Weight Loss
Key Publications February 21, 2017

Semaglutide and cardiovascular outcomes in patients with type 2 diabetes.

N Engl J Med. 2016;375:1834-1844

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T, SUSTAIN-6 Investigators
Cardiovascular Disease Clinical Trials Diabetes
Key Publications February 20, 2017

Impact of hypertension on cognitive function: A scientific statement from the American Heart Association.

Hypertension. 2016;68:e67-e94

Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB et al.
Brain Health Cardiovascular Disease Hypertension
Key Publications February 17, 2017

Trends in antihypertensive medication use among US patients with resistant hypertension, 2008 to 2014.

Hypertension. 2016;68:1349-1354

Hwang AY, Dave C, Smith SM
Cardiovascular Disease Epidemiology Hypertension
Key Publications February 17, 2017

Cardiovascular risk factors and masked hypertension: The Jackson Heart Study.

Hypertension. 2016;68:1475-1482

Bromfield SG, Shimbo D, Booth JN 3rd, Correa A, Ogedegbe G, Carson AP, Muntner P.
Cardiovascular Disease Hypertension Physical Activity/Exercise
Key Publications February 15, 2017

Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.

Curr Opin Lipidol. 2016;27:615-622

Koopen AM, Groen AK, Nieuwdorp M
Cardiometabolic Risk Cardiovascular Disease Metabolism
Key Publications February 14, 2017

The future of lipid guidelines.

Curr Opin Lipidol. 2016;27:585-591

Robinson JG
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications February 14, 2017

HDL infusion for the management of atherosclerosis: current developments and new directions.

Curr Opin Lipidol. 2016;27:592-596

Zheng KH, Stroes ES
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications February 13, 2017

Clinical trials with cholesteryl ester transfer protein inhibitors.

Curr Opin Lipidol. 2016;2:545-549

Di Bartolo BA, Duong M, Nicholls SJ
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications February 13, 2017

Risk prediction: Are we there yet?

Circulation. 2016;134:1441-1443

Jensen JK
Cardiovascular Disease Epidemiology Prevention
Key Publications February 13, 2017

New oral agents for treating dyslipidemia.

Curr Opin Lipidol. 2016;27:579-584

Gryn SE, Hegele RA
Cardiovascular Disease Lipids/Lipoproteins Prevention
of 212